ZTS241220C200000
- 0.13
- +0.08+160.00%
Zoetis Newsroom
Zoetis Inc. (ZTS): Navigating Consumer Trends and Revolutionizing Pet Care With Innovation
Zoetis Inc. (ZTS) Management Presents at Jefferies London Healthcare Conference (Transcript)
Zoetis to Participate in the Piper Sandler 36th Annual Healthcare Conference
Is Zoetis Inc. (NYSE:ZTS) Trading At A 29% Discount?
S&P Sees Some Signs of a US Credit Bubble as Spreads Tighten
Quality Cyclicals Are Expected to Continue Going Up, Here Are the Top-rated by Morgan Stanley
US Manufacturing Index Rises To 43, Highest Since 2020
Vanguard Health Care Fund's Strategic Moves in Q3 2024: A Focus on Zoetis Inc
Zoetis Announces Major Leadership Changes for Growth
The Arthritis Foundation Welcomes Zoetis as Two-Year National Presenting Sponsor of Jingle Bell Run and Walk to Cure Arthritis
Piper Sandler Maintains Zoetis(ZTS.US) With Buy Rating, Maintains Target Price $210
Piper Sandler Issues a Buy Rating on Zoetis (ZTS)
Express News | Zoetis Appoints Jamie Brannan to Newly Created Chief Commercial Officer Role
Is Zoetis Inc. (ZTS) The Best Pet Stock To Invest In According To Analysts?
Zoetis to Participate in Jefferies London Healthcare Conference
Results: Zoetis Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Jefferies Cuts Zoetis' Price Target to $200 From $210
Wall Street Rallies On Election Day, Palantir Skyrockets, Bitcoin Tops $70,000: What's Driving Markets Tuesday?
10 Health Care Stocks Whale Activity In Today's Session
Morgan Stanley Maintains Zoetis(ZTS.US) With Buy Rating, Maintains Target Price $248